BioCentury | Oct 15, 2012
Clinical News

GST P1-1 stroke assay diagnostic data

...proteins previously identified as early markers of brain damage associated with stroke showing that glutathione S-transferase P1-1 (GST P1-1...
...and 132 healthy controls. Data were published in PLoS ONE. Proteome said that testing for GST P1-1...
...Product: GST P1-1 stroke assay Business: Diagnostic Molecular target: Glutathione S-transferase P1-1 (GST P1-1) Description: Blood test measuring glutathione S-transferase P1-1 (GST P1-1...
BioCentury | Nov 22, 2010
Company News

Epigenomics, Predictive Biosciences deal

...a 2009 option to commercialize a prostate cancer test in the U.S. incorporating Epigenomics' glutathione S-transferase P1-1 (GST P1-1...
BioCentury | Oct 12, 2009
Clinical News

Telcyta: Updated Phase I/IIa data

...Business: Cancer Molecular target: Glutathione S-transferase P1-1 (GST P1-1) Description: Small molecule glutathione analog prodrug activated by glutathione S-transferase P1-1 (GST P1-1...
BioCentury | Jun 8, 2009
Clinical News

Telcyta: Additional Phase III data

...Business: Cancer Molecular target: Glutathione S-transferase P1-1 (GST P1-1) Description: Small molecule glutathione analog prodrug activated by glutathione S-transferase P1-1 (GST P1-1...
BioCentury | May 4, 2009
Company News

Epigenomics, Predictive Biosciences deal

...biosciences received a non-exclusive, U.S. license to develop and commercialize Epigenomics' glutathione S-transferase P1-1 ( GSTP1 ; GST P1-1...
BioCentury | Apr 16, 2009
Distillery Therapeutics

Indication: Cancer

...of MGST1 in drug resistance. Telik Inc.'s TLK286, a glutathione analog activated by glutathione S-transferase P1-1 (GSTP1; GST P1-1...
BioCentury | Nov 3, 2008
Clinical News

Telcyta: Phase III data

...Business: Cancer Molecular target: Glutathione S-transferase P1-1 (GST P1-1) Description: Small molecule glutathione analog prodrug activated by glutathione S-transferase P1-1 (GST P1-1...
BioCentury | Oct 22, 2007
Clinical News

Telcyta: Phase III ongoing

...Business: Cancer Molecular target: Glutathione S-transferase P1-1 (GST P1-1) Description: Small molecule glutathione analog prodrug activated by glutathione S-transferase P1-1 (GST P1-1...
BioCentury | Oct 16, 2007
Clinical News

FDA lifts Telcyta hold

...hold later the same month. Telcyta is a small molecule glutathione analog prodrug activated by glutathione S-transferase P1-1...
BioCentury | Jun 25, 2007
Clinical News

Telcyta: Phase III resumed

...Business: Cancer Molecular target: Glutathione S-transferase P1-1 (GST P1-1) Description: Small molecule glutathione analog prodrug activated by glutathione S-transferase P1-1 (GST P1-1...
Items per page:
1 - 10 of 92